Amanote Research
Register
Sign In
Cross-National Comparison of Biosimilar Medicines : Market Penetration and Competition With Originators
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.07.347
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
September 1, 2018
Authors
H Kwon
S Bae
J Yoon
Publisher
Elsevier BV
Related search
Biosimilar Medicines: Creating Sustainable Competition in an Era of a New Patent Cliff in Biological Medicines
Journal of Pharmaceutical Policy and Practice
Toxicology
Pharmaceutics
Pharmacology
Health Policy
Php22 - Is the European Biosimilar Medicines Market Becoming Unsustainable? An Exploration of the Combined Impact of Competition, Interchangeability, Procurement, and Pricing
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Benefits and Drawbacks of Moving to Biosimilar Medicines
Prescriber
Pharmacology
National Produce Market Barrier Penetration: The Georgia Case
Hortscience: A Publication of the American Society for Hortcultural Science
Horticulture
Php217 - Time to Market and Price Comparison for Biosimilar Drugs in Eu5
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
European Medicines Agency Workshop on Biosimilar Monoclonal Antibodies
mAbs
Allergy
Immunology
Trade Union Research and Cross-National Comparison
European Journal of Industrial Relations
Management
Business
Organizational Behavior
Human Resource Management
Strategy
Innovation
Accounting
Management of Technology
Asian Women Leadership, a Cross-National and Cross-Sector Comparison.
Gender, Work and Organization
Gender Studies
Human Resource Management
Organizational Behavior
Market Competition and Selection
